23023-13-4

Basic information

• Product Name: 1-(3,4-METHYLENEDIOXY)PHENYL-2-BUTANONE
• Synonyms: 1-(1,3-benzodioxol-5-yl)-2-butanon;1-(3,4-METHYLENEDIOXY)PHENYL-2-BUTANONE;4-(1,3-BENZODIOXOL-5-YL)-2-BUTANONE;ETHYL PIPERONYL KETONE;TIMTEC-BB SBB008632;1-(1,3-Benzodioxol-5-yl)-2-butanone~Ethyl piperonyl ketone;1-(1,3-benzodioxol-5-yl)butan-2-one;1-(1,3-benzodioxol-5-yl)-2-butanone
• CAS NO: 23023-13-4
• Molecular Formula: C₁₁H₁₂O₃
• Molecular Weight: 192.21
• EINECS: 245-384-2
• Mol File: 23023-13-4.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 98°C 0,1mm
• Flash Point: 98°C/0.1mm
• Appearance: /
• Density: 1.175g/cm³
• Vapor Pressure: 0.00198mmHg at 25°C
• Refractive Index: 1.5375
• Water Solubility: It is insoluble in water.
• BRN: 6508240
• CAS DataBase Reference: 1-(3,4-METHYLENEDIOXY)PHENYL-2-BUTANONE(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(3,4-METHYLENEDIOXY)PHENYL-2-BUTANONE(23023-13-4)
• EPA Substance Registry System: 1-(3,4-METHYLENEDIOXY)PHENYL-2-BUTANONE(23023-13-4)

Safety Data

• Hazard Codes: Xn
• Statements: 22
• Safety Statements: 23-24/25
• TSCA: Yes
• Hazardous Substances Data: 23023-13-4(Hazardous Substances Data)

Usage

Uses

1-(3,4-Methylenedioxy)phenyl-2-butanone, is used as a pharmaceutical intermediate.

InChI:InChI=1/C11H12O3/c1-2-9(12)5-8-3-4-10-11(6-8)14-7-13-10/h3-4,6H,2,5,7H2,1H3

Upstream product

• 6890-31-9 1-(1,3-benzodioxol-5-yl)butan-1-ol 
• 16929-04-7 (E)-5-(but-1-en-1-yl)benzo[d][1,3]dioxole 
• 120-57-0 piperonal 

Downstream Products

• 107447-03-0 1-(3,4-methylenedioxyphenyl)-2-butanamine 
• 128767-12-4 1-(3,4-Methylenedioxyphenyl)-2-methylaminobutane hydrochloride 
• 135795-90-3 MBDB 

Relevant articles and documents

Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: Representatives of a novel therapeutic class

The α-ethyl phenethylamine derivative 1-(1,3-benzodioxol-5-yl)-2-butanamine was prepared. An asymmetric synthesis was used to prepare the enantiomers of this compound and the related α-methyl homologue (MDA). The racemates and enantiomers of both compounds were evaluated in the two-lever drug discrimination assay in rats trained to discriminate saline from 0.08 mg/kg of LSD tartrate. Stimulus generalization occurred with the racemate and the R-(-)enantiomer of the α-methyl homologue and the S-(+)enantiomer of the α-ethyl primary amine. No generalization occurred with the other enantiomers or with the N-methyl derivatives of either series. Human psychopharmacology studies revealed that the N-methyl derivative of the title compound was nonhallucinogenic and that it had a new, novel psychoactive effect. It is suggested that this compound is the prototype of a new pharmacologic class that may have value in facilitating psychotherapy and that this class be designated as entactogens.